Goichot B, Wicky C, Grunenberger F, Schlienger J L
Service de Médecine Interne et de Nutrition, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg, avenue Molière, 67098 Strasbourg Cedex.
Ann Endocrinol (Paris). 2000 Nov;61(5):452-8.
Prolonged corticosteroid treatment is considered to be the main cause of adrenal insufficiency (AI). AI is due to adrenal atrophy caused by the inhibition of ACTH secretion. Risk factors for AI after corticosteroid treatment remain unknown. Various functional tests, particularly the "standard" Synacthene 250 microg, demonstrate frequent abnormal responses in these patients. However, these abnormalities are not predictive of the risk of AI in particular in case of stress. More recent tests (CRH, "low dose" Synacthene) need to be further evaluated in this situation. Several recent studies in animals and in humans have demonstrated that the need for glucocorticoid coverage during a surgical stress has been greatly overestimated and that maintenance of the usual daily dose seems to be sufficient and safe in most patients with minor surgical stress. Revision of guidelines for more important surgical stress or for other medical conditions in patient treated with glucocorticoids is necessary.
长期使用皮质类固醇治疗被认为是肾上腺功能不全(AI)的主要原因。AI是由于促肾上腺皮质激素(ACTH)分泌受抑制导致肾上腺萎缩所致。皮质类固醇治疗后发生AI的危险因素仍不清楚。各种功能试验,尤其是“标准”的250微克辛纳科(Synacthene)试验,在这些患者中显示出频繁的异常反应。然而,这些异常并不能预测AI的风险,特别是在应激情况下。在这种情况下,需要进一步评估更新的试验(促肾上腺皮质激素释放激素(CRH)、“低剂量”辛纳科试验)。最近在动物和人类中的几项研究表明,手术应激期间对糖皮质激素覆盖的需求被大大高估了,而且对于大多数手术应激较小的患者,维持常规日剂量似乎就足够且安全。有必要修订针对接受糖皮质激素治疗的患者进行更重大手术应激或其他医疗状况的指南。